NASDAQ: MBRXMoleculin Biotech Inc Stock Ownership - Who owns Moleculin Biotech?
Insider buying vs selling
Have Moleculin Biotech Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Donald H. Picker | Chief Science Officer | 2026-06-22 | 21 | $3.12 | $65.52Sell |
| Walter V. Klemp | CEO and President | 2026-06-22 | 88 | $3.12 | $274.56Sell |
| Jonathan P. Foster | Chief Financial Officer | 2026-06-22 | 41 | $3.12 | $127.92Sell |
| Walter V. Klemp | CEO and President | 2026-06-20 | 37 | $2.88 | $106.56Sell |
| Jonathan P. Foster | Chief Financial Officer | 2026-06-20 | 31 | $2.88 | $89.28Sell |
| Donald H. Picker | Chief Science Officer | 2026-06-20 | 13 | $2.88 | $37.44Sell |
| Donald H. Picker | Chief Science Officer | 2025-11-04 | 2,131 | $0.50 | $1.06kSell |
| Walter V. Klemp | CEO and President | 2025-11-04 | 7,001 | $0.50 | $3.48kSell |
| Jonathan P. Foster | Chief Financial Officer | 2025-11-04 | 5,023 | $0.50 | $2.50kSell |
MBRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when MBRX insiders and whales buy or sell their stock.
MBRX Shareholders
What type of owners hold Moleculin Biotech Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Waldemar Priebe | 18.72% | 3,645,573 | $2.15M | Insider |
| Walter V. Klemp | 8.42% | 1,639,340 | $968.85k | Insider |
| Donald H. Picker | 3.73% | 726,086 | $429.12k | Insider |
| Jonathan P. Foster | 1.57% | 305,673 | $180.65k | Insider |
| Robert E. George | 0.08% | 14,660 | $8.66k | Insider |
| Jacqueline Northcut | 0.01% | 1,000 | $591.00 | Insider |
| Geode Capital Management LLC | 0.00% | 47 | $27.78 | Institution |
| Geodec | 0.00% | 47 | $27.78 | Institution |
| Vanguard Capital Management LLC | 0.00% | 42 | $24.82 | Institution |
| Vangrd | 0.00% | 42 | $24.82 | Institution |
MBRX vs Biotech Stocks
Moleculin Biotech Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.